Laura Stepon Therapy - Company finances
|
EUR
|
2022
From: 2022-07-14
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 18,460 | 50,218 | 95,534 | 85,372 |
| Profit before tax | 12,528 | 12,889 | 31,291 | 41,553 |
| Net profit | 12,528 | 12,243 | 29,718 | 39,138 |
| Equity | 12,530 | 24,773 | 54,492 | 93,629 |
| Liabilities | 1,526 | 2,764 | 7,642 | 1,002 |
| Non-current assets | 12,842 | 11,502 | 10,162 | 9,618 |
| Current assets | 1,214 | 16,035 | 51,831 | 84,869 |
| Total assets | 14,056 | 27,537 | 61,993 | 94,487 |
|
Taxes paid
|
||||
| STI taxes | - | 4,475 | 14,552 | 22,017 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +172.0% | +90.2% | -10.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 89.1% | 44.5% | 47.9% | 41.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 49.4% | 54.5% | 41.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 67.9% | 24.4% | 31.1% | 45.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 67.9% | 25.7% | 32.8% | 48.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Laura Stepon Therapy - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-09-01 | 2023-09-30 | 58.63 |
| 2023-04-03 | 2023-04-30 | 58.63 |
| 2022-11-03 | 2022-11-30 | 50.95 |
Laura Stepon Therapy - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-12-01 | 2025-12-22 | 0.12 |
| 2025-10-30 | 2025-11-25 | 0.1 |
| 2025-02-28 | 2025-02-28 | 12.0 |
| 2025-02-25 | 2025-02-25 | 15.14 |
| 2025-02-19 | 2025-02-24 | 9.17 |
| 2025-01-30 | 2025-02-18 | 1.17 |
| 2024-12-31 | 2025-01-01 | 5.16 |
| 2024-12-30 | 2024-12-30 | 6364.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Laura Stepon Therapy, MB (company code 306115998) is a Lithuanian small partnership operating in traditional, complementary and alternative medicine activities. In 2025, the latest financial year, the company generated revenue of €85.4K, down 10.6% year on year from €95.5K in 2024. Despite the lower turnover, profitability improved strongly: net profit rose to €39.1K from €29.7K, and profit margin increased to 45.8% from 31.1% a year earlier. Over the two-year period from 2023 to 2025, revenue increased from €50.2K to €85.4K, while net profit advanced from €12.2K to €39.1K, showing a clear upward trend in earnings capacity. The balance sheet also strengthened materially. Total assets reached €94.5K at the end of 2025, with equity of €93.6K and liabilities of only €1.0K. The equity ratio stood at 99.1% and debt-to-equity at 0.01, indicating very low leverage. Return on equity was 41.8% and return on assets 41.4%, supported by asset turnover of 0.90x. Short-term assets dominated the asset base in 2025, reflecting a highly liquid position.